T Cell Ig and Mucin Domain–Containing Protein 3 Is Recruited to the Immune Synapse, Disrupts Stable Synapse Formation, and Associates with Receptor Phosphatases
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
CD8+ CTLs are adept at killing virally infected cells and cancer cells and releasing cytokines (e.g., IFN-γ) to aid this response. However, during cancer and chronic viral infections, such as with HIV, this CTL response is progressively impaired due to a process called T cell exhaustion. Previous work has shown that the glycoprotein T cell Ig and mucin domain–containing protein 3 (Tim-3) plays a functional role in establishing T cell exhaustion. Tim-3 is highly upregulated on virus and tumor Ag-specific CD8+ T cells, and antagonizing Tim-3 helps restore function of CD8+ T cells. However, very little is known of how Tim-3 signals in CTLs. In this study, we assessed the role of Tim-3 at the immunological synapse as well as its interaction with proximal TCR signaling molecules in primary human CD8+ T cells. Tim-3 was found within CD8+ T cell lipid rafts at the immunological synapse. Blocking Tim-3 resulted in a significantly greater number of stable synapses being formed between Tim-3hiCD8+ T cells and target cells, suggesting that Tim-3 plays a functional role in synapse formation. Further, we confirmed that Tim-3 interacts with Lck, but not the phospho-active form of Lck. Finally, Tim-3 colocalizes with receptor phosphatases CD45 and CD148, an interaction that is enhanced in the presence of the Tim-3 ligand, galectin-9. Thus, Tim-3 interacts with multiple signaling molecules at the immunological synapse, and characterizing these interactions could aid in the development of therapeutics to restore Tim-3–mediated immune dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another inhibitory signaling mechanism discussed is the colocalization of TIM‐3 with CD45 and CD148 at the immunological synapse, where T cell function was suppressed [313].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [313]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · cited 1×
“However, these mechanisms also limit T cell responses to cancer Ags and chronic infection (1, 2).”
BackgroundMolecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114 · cited 1×
“Formation of an immunological synapse requires a T cell in conjugate with a target cell to provide a TCR stimulus and surface ligands/receptors on both cells to coordinate multiple costimulatory/inhibitory and immune accessory molecules (35, 36).”
BackgroundBlackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062 · cited 1×
“In addition, antagonizing these receptors with Abs or soluble fusion proteins results in partial rescue of effector function (6).”
BackgroundThe Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057 · cited 2×
“Tim-3 is carbohydrate dependent (17), and as such, galectin-9’s”
BackgroundWherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,528 · cited 1×
“However, these mechanisms also limit T cell responses to cancer Ags and chronic infection (1, 2).”
BackgroundMonney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., & Saito, T. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112741 · Cited by 1,161 · cited 1×
“Similarly, PD-1 has also been found at the immunological synapse and negatively effects synapse stability, as defined by concentrated and centered CD3 at the T cell synapse (38).”
BackgroundCooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Jin, H.-T., Anderson, A. C., Tan, W. G., West, E. E., Ha, S.-J., Araki, K., Freeman, G. J., Kuchroo, V. K., & Ahmed, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009731107 · Cited by 858
Jones, R. B., Ndhlovu, L. C., Barbour, J. D., Sheth, P. M., Jha, A. R., Long, B. R., Wong, J. C., Satkunarajah, M., Schweneker, M., Chapman, J. M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081398 · Cited by 753 · cited 2×
“Soluble Tim-3 (sTim-3) was produced and purified as previously described (4) and biotinylated using the EZ-Link Sulfo-NHS-LC-Biotinylation Kit (Thermo Scientific, Rockford, IL).”
BackgroundMethodSelf-citation
Cited by
Items 101–147 of 147
Increased Tim-3 and Gal-9 expression are related to poor prognosis in Oral Squamous Cell CarcinomaPreprint
Ahmed, S., & Shaikh, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1418045/v1 · Cited by 4
Li, Y., Zheng, R., Pan, B., Wang, X., Zhang, L., Gao, H., & Li, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1713199 · Cited by 4
Wang, Y., Wu, Y., Shen, Y., Chen, Y., Zhao, Y., Zeng, X., & He, K. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101965 · Cited by 3
“24 On the other hand, Tim-3 might also exert a co-stimulatory effect, facilitating TCR signaling, maintaining T-cell function, delaying exhaustion, or exerting a “rescue” role.”
Gabel, M., Knauss, A., Neurath, M. F., & Weigmann, B. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02631-z · Cited by 3
“Simultaneously, stimulation of TIM-3 via Gal-9 can upregulate the expression of CD45 which can facilitate the dephosphorylation of the active form of Lck thereby diminish Lck activity and dampening TCR signaling [63].”
Meyaard, L., & van der Vlist, M. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083024-025659 · Cited by 3
Zhang, B., Muhetarijiang, M., Sun, X., Wu, Y., Justin, R., Li, Z., Chen, T., Zhou, D., & Hu, X. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm43846 · Cited by 3
“[66] demonstrated that MHC-TCR binding induces the translocation of TIM-3 from lipid rafts to the immune synapse, where it is ligated to GAL-9 and interacts with CD45 or CD148, subsequently regulating Lck activity (see Fig.”
TIM-3 in AML: pathogenic roles and therapeutic targetability
Zhong, L., & Samarkhazan, H. S. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02133-3 · Cited by 3
“While there is still much to discover, research has demonstrated that when Gal-9 and/or CEACAM1 engage TIM-3, it causes the phos - phorylation of two cytoplasmic tyrosines, Y256 and Y263, which bind to BAT3, an HLA-B-associated gene [ 43 , 45 , 46 ].”
Anderson, S. M., Choi, J., Cushman, E. M., Leander, M., Raman, S., & Senes, A. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf305 · Cited by 3
Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells
Lu, J., Veler, A., Simonetti, B., Raj, T., Chou, P. H., Cross, S., Phillips, A. M., Ruan, X., Huynh, L., Dowsey, A. W., et al. (2023) · Cells · doi:10.3390/cells12212558 · Cited by 3
“Substantial intracellular localization of TIM3 has been described, including in Rab5 labeled vesicles and the trans -Golgi network, and TIM3 accumulates at the cellular interface with APCs [23,24].”
BackgroundXu, S., Yang, L., He, Y., Chen, Y., Qin, F., & Hu, W. (2025) · Discover Oncology · doi:10.1007/s12672-025-02673-2 · Cited by 3
“In the absence of ligand engagement, BAT3 interacts with the cytoplasmic tail of TIM-3, facilitating the recruitment of lymphocyte-specific protein tyrosine kinase to maintain T cell function [24].”
The Signaling Networks of TIM-3, TGF-β, and STING in Glioblastoma
Ahmady, F., Carnie, B. M. H., Anderson, G. E. C., Achari, E., Sharma, A., Achuthan, A. A., Kannourakis, G., & Luwor, R. B. (2026) · Cells · doi:10.3390/cells15110991 · Cited by 2
“Upon T cell activation, TIM-3 complex is transported from lipid rafts, where they reside, to immune synapses [34].”
InfluentialGayen, S., Mukherjee, S., Dasgupta, S., & Roy, S. (2024) · APOPTOSIS · doi:10.1007/s10495-024-02022-8 · Cited by 1
“As a result of the disruption of immune synapse formation caused by the recruitment of phosphatases, leads to the development of TIM3 dependent inhibitory signaling on T-cells activation [66].”
Regulation of mast cell function by TIM-1 and TIM-3 signaling
Phong, B. L. (2016) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Jajosky, A. N. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5874 · Cited by 1
Clayton, K., & Ostrowski, M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_210-1 · Cited by 1
Self-citationSchwarzbich, M.-A. (2020) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1
Lhuillier, C. (2016) · theses.fr (ABES) · doi:10.70675/d067b27ez2081z49d2z94f5z87680adf071c · Cited by 1
Regulation of T cell responses by the surface receptor Tim-3
Gorman, J. V. (2014) · doi:10.17077/etd.pcnchex2
“However, it is possible that both Tim-3 and Tim-3 Th1 cells are expressing sufficient amounts other Galectin-9 receptors that induce cell death [167, 228, 288, 289].”
BackgroundRole of the TIGIT Immune Checkpoint Pathway in the Eradication of HIV Infection.
Chew, G. M. (2017) · ScholarSpace (University of Hawaii at Manoa)
Self-citationGalectin-9 inhibits B cell receptor (BCR) signaling by regulating BCR organization and mobility
Cao, A. (2017) · TSpace (University of Toronto)
Clayton, K., & Ostrowski, M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7101-5_210
Self-citationResearch Progress on the Relationship between Tumor Radiotherapy and TIM-3
矫, 晨. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1291215
Slaats, J., Dieteren, C. E. J., Wagena, E., Wolf, L. E., Raaijmakers, T. K., van der Laak, J. A. W. M., Figdor, C. G., Weigelin, B., & Friedl, P. (2023) · doi:10.1158/2326-6066.22544286
Slaats, J., Dieteren, C. E. J., Wagena, E., Wolf, L., Raaijmakers, T. K., van der Laak, J. A. W. M., Figdor, C. G., Weigelin, B., & Friedl, P. (2023) · doi:10.1158/2326-6066.22544304
TIM-3 blockade as a therapeutic approach for diffuse intrinsic pontine glioma
Ausejo-Mauleón, I. (. (2023) · Depósito Académico Digital Universidad de Navarra (University of Navarra) · doi:10.15581/10171/69095
The Biology of Immune Checkpoint Blockade
Bullock, T. N. J. (2024) · Wiley eBooks · doi:10.1002/9781119824572.ch10
Alexander, T. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10379
Allela, O. Q. B., Shareef, A., Bishoyi, A. K., Oweis, R. J., Ballal, S., Singh, A., Sinha, A., Ray, S., Sameer, H. N., Yaseen, A., et al. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2571960 · Cited by 2
Girardin, M. (2023) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.5075/epfl-thesis-8912
Bangayan, N. J. (2023) · eScholarship (California Digital Library)
Tim-3+ Treg control viral persistence and effector T cell responses.
Nieves-Rosado, H. M. (2024) · D-Scholarship@Pitt (University of Pittsburgh)
Dolui, B., Majumdar, B., Bandyopadhyay, A., Desai, K. V., & BASU, A. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111096 · Cited by 1
“In the context of T cell receptor (TCR) signaling, HLA-B-associated transcript 3 (Bat3) reverses the negative regulatory effect of TIM-3 and enhances T cell responses (20, 21).”
Chen, J. H. K. (2022) · TSpace (University of Toronto)
Inhibitory receptor agonists: Emerging strategies in immune modulation
Adam, K. R., Suhail, A., Kuchroo, V. K., & Vignali, D. A. A. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20241217 · Cited by 1
Rôle de la Neuropiline-1 dans les fonctions effectrices des lymphocytes T CD8 antitumoraux
Leclerc, M. (2018) · theses.fr (ABES) · doi:10.70675/13aee211zad7bz4b07z9a5fz29b15750d99c
Wierz, M. (2020) · theses.fr (ABES) · doi:10.70675/80454a47z3b6bz4b8bza0c3z684d69f087b3 · Cited by 1
Immunomodulatory Properties of Galectin-9 : Experimental and Translational Investigations
Tran, T. B. T. (2021) · theses.fr (ABES) · doi:10.70675/231595d6zb499z40e7zbdc1z78a06553b688
TIM-3 in Cardiovascular Disease
Yousif, L. I. E., Sijtema, A. G., Chevalier, M. J., de Boer, R. A., & Meijers, W. C. (2026) · Current Heart Failure Reports · doi:10.1007/s11897-026-00755-y
“CD8 + T cells directly eliminate infected and malignant cells and secrete cytokines such as IFN-γ to support this response [ 33].”
InfluentialPouxvielh, K. (2024) · theses.fr (ABES) · doi:10.70675/78db399bzce6az4d34z9634zfbe1e4580685
Trioën, C. (2024) · theses.fr (ABES) · doi:10.70675/7c132518z8997z4d01z8084z87c06a661e5a
Toumi, R., Guenette, S., & Oda, S. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1819470
Huang, Y., Li, J., Qin, Y., Qie, B., Wang, Q., Liu, C., & Zhu, Y. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179308
T-cell immunity in anti-tumor battle
Qin, Y., Yan, K., Li, D., Zhang, J., Guo, Z., Zhang, Y., & Lü, W. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01483-y
Min, J., Tang, J., Hu, M., Suting, L. I., & Tian, X. (2026) · Biomedicines · doi:10.3390/biomedicines14112583
Quilbe, A., Mustapha, R., Duchêne, B., Kumar, A., Werkmeister, E., Leteurtre, E., Moralès, O., Jonckheere, N., Seuningen, I. V., & Delhem, N. (2023) · doi:10.3389/fimmu.2023.1267279.s002
Metadata
- Authors
- Clayton, K. L., Haaland, M. S., Douglas-Vail, M. B., Mujib, S., Chew, G. M., Ndhlovu, L. C., & Ostrowski, M. A.
- Affiliations
- University of Toronto (CA)
- University of Hawaiʻi at Mānoa (US)
- St. Michael's Hospital (CA)
- Corresponding author
- Ostrowski, Mario A
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01
- Volume
- 192
- Issue
- 2
- Pages
- 782-791
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4214929
- OpenAlex
- W2121603793
- Cited by
- 134
- References
- 48
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 14 · 2023: 15 · 2022: 8 · 2021: 19 · 2020: 13 · 2019: 3 · 2018: 8 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 8
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases (R56AI083112, P30AI027763)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- TIM-3, immunological synapse, CD8+ T cells, T cell exhaustion, galectin-9, Lck, CD45, CD148, lipid rafts, T cell signaling
- MeSH terms
- Hepatitis A Virus Cellular Receptor 2, Humans, Membrane Proteins, Phosphoric Monoester Hydrolases, Synapses, Signal Transduction, HIV Infections, Leukocyte Common Antigens, CD8-Positive T-Lymphocytes, Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Galectins, Receptor-Like Protein Tyrosine Phosphatases, Class 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.